VANCOUVER, BC--(Marketwired - September 01, 2015) - According to a new report on the European markets for spinal implants and vertebral compression fracture (VCF) by iData Research (www.idataresearch.com), the EUR168 million European VCF device market will experience growing procedural volume driven by an elderly population suffering from osteoporosis and the popularization of percutaneous vertebral augmentation (PVA) treatment. PVA is characterized by a high average selling price (ASP) and is anticipated to grow at an accelerating rate. This market includes Medtronic's kyphoplasty and newer cavity creating and height restoring PVA techniques.
"The ASP per procedure can vary significantly depending on the products used and how many levels are treated," explains Dr.
